MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H20053397

April 25, 2024

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15g

化学药品

April 25, 2024

Company Information

Applicant Company

北京市怀柔区北房镇恒利街72号

Manufacturing Company

北京市怀柔区北房镇恒利街72号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁胶囊 - NMPA 批准文号 | MedPath